This is a Validated Antibody Database (VAD) review about human PDZ binding kinase, based on 2 published articles (read how Labome selects the articles), using PDZ binding kinase antibody in all methods. It is aimed to help Labome visitors find the most suited PDZ binding kinase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PDZ binding kinase synonym: CT84; HEL164; Nori-3; SPK; TOPK; lymphokine-activated killer T-cell-originated protein kinase; MAPKK-like protein kinase; T-LAK cell-originated protein kinase; cancer/testis antigen 84; epididymis luminal protein 164; serine/threonine protein kinase; spermatogenesis-related protein kinase
Knockout validation
| Cell Signaling Technology rabbit polyclonal |
| Cell Signaling Technology PDZ binding kinase antibody (Cell Signaling Technology, 4942) was used in western blot knockout validation on human samples (fig 5a). Cell Signal (2017) ncbi |
Cell Signaling Technology
| rabbit polyclonal |
| Cell Signaling Technology PDZ binding kinase antibody (Cell Signaling Technology, 4941) was used in western blot on human samples (fig 3c). Cell Signal (2017) ncbi |
| rabbit polyclonal |
| Cell Signaling Technology PDZ binding kinase antibody (Cell Signaling Technology, 4942) was used in western blot knockout validation on human samples (fig 5a). Cell Signal (2017) ncbi |
| rabbit polyclonal |
| In order to define the role of T-LAK cell-originated protein kinase in colorectal cancer metastasis, Cell Signaling Technology PDZ binding kinase antibody (CST, 4942) was used in immunoprecipitation on human samples (fig 1d) and in western blot on human samples (fig 1d). EBioMedicine (2017) ncbi |
| rabbit polyclonal |
| In order to define the role of T-LAK cell-originated protein kinase in colorectal cancer metastasis, Cell Signaling Technology PDZ binding kinase antibody (CST, 4941) was used in western blot on human samples (fig 2b). EBioMedicine (2017) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
